Gritstone secures CEPI funding to test Covid vaccine; first focus is South Africa

Gritstone secures CEPI funding to test Covid vaccine; first focus is South Africa

Source: 
MedCity News
snippet: 

Gritstone bio is developing Covid-19 vaccines that use self-amplifying messenger RNA, which is intended to further boost the immune response compared to mRNA alone. The company also says its vaccine candidates may be able to protect against variants of the novel coronavirus.